Company Filing History:
3 out of 116 
1 out of 4 
1 out of 12 Years Active: 2005-2015
Title: Innovative Contributions of Kenton Zavitz in Neurodegenerative Disorder Treatments
Introduction
Kenton Zavitz, an accomplished inventor based in Salt Lake City, UT, has made significant strides in the field of biomedical research, particularly in the treatment of Alzheimer’s disease. With a portfolio of seven patents, his innovative work focuses on novel compounds aimed at addressing neurodegenerative disorders.
Latest Patents
Zavitz's latest patents are groundbreaking in their design and functionality. One patent is centered around "Compounds for Alzheimer's Disease," which discloses novel indole and tetrahydroindole core compounds. These compounds are proven useful for the treatment of disorders linked to defects in vesicular transport, such as axonal transport. Additionally, another patent within the same realm provides a range of compounds aimed at treating neurodegenerative diseases, including Alzheimer’s and dementia. These compounds feature varying substituents such as -L-C(=O)OH, -L-S(=O)(Calkyl), and many more, where “L” denotes a linker, showing Zavitz's commitment to developing targeted therapies.
Career Highlights
Throughout his career, Zavitz has contributed to significant advancements in the biotech field. His work at companies like Myriad Genetics, Inc. has honed his expertise in drug development. This hands-on experience has equipped Zavitz with the necessary skills and insights to make notable contributions to science and medicine.
Collaborations
Kenton Zavitz has had the opportunity to collaborate with talented individuals such as Scott Morham and Rachel M. Slade. These collaborations have likely enhanced his innovative processes, providing a rich exchange of ideas and knowledge in his pursuit of effective treatments for neurodegenerative disorders.
Conclusion
Kenton Zavitz stands out as a noteworthy inventor in the arena of Alzheimer's disease research. With his patents focused on novel compound development, he is contributing significantly to the medical community's understanding and treatment of neurodegenerative diseases. His career achievements and collaborations undoubtedly set a strong foundation for ongoing innovations in this critical field.